In studies, after 52 weeks, participants on the highest dose of Mounjaro (15 mg per week): Lowered their total cholesterol by about 5.6 percent Lowered their triglycerides by 22.5 percent Lowered their LDL (bad) cholesterol by 7.9 percent Lowered their VLDL cholesterol by 21.8 percent Increased their HDL (good) cholesterol by 10.8 percent Additionally, a meta-analysis (analysis of data from several clinical trials) from The Lancet found that GLP-1 receptor agonist medications, including semaglutide (the active ingredient in Wegovy), lowered cardiovascular risk
However, if there's a related health condition, like type 2 diabetes, coverage might be more straightforward
The Trump administration has cut thousands of jobs at the FDA in recent weeks, which could make it even harder for the agency to monitor compounding pharmacies
Experts discuss benefits, challenges of anti-obesity drugs in The Permanente Journal An expert panel discussion convened by The Permanente Journal explored the clinical, systemic, and societal impact of anti-obesity drugs like Ozempic and Wegovy
Proteomics of fibrin amyloid microclots in long COVID/post-acute sequelae of COVID-19 (PASC) shows many entrapped pro-inflammatory molecules that may also contribute to a failed fibrinolytic system